Cite
APA Citation
Honda, M., Matsuda, C., Tanaka, C., Kondo, K., Takahashi, T., Kosugi, C., Tokunaga, Y., Takemoto, H., Kim, H. M., Sakamoto, J., Oba, K., & Mishima, H. (n.d.). 479PA phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy for colorectal cancer: The AIRS study. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095509073.0x000038